Platelet-rich therapy in the treatment of patients with hip fractures: A single centre, parallel group, participantblinded, randomised controlled trial

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Griffin, Xavier L ^a,b   Achten, Juul ^a   Parsons, Nick ^a   Costa, Matt L ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCREW; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; FEMALE; FEMUR FRACTURE; FOLLOW UP; FRACTURE FIXATION; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OSTEOSYNTHESIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RISK REDUCTION; THROMBOCYTE RICH PLASMA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84880422234     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002583     Document Type: Article

References (23)

1. Hall M, Band P, Meislin R. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2010;18:17A.
2. Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 2009;91:987-96.
3. Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 2009;30:4956-66.
4. Redler LH, Thompson SA, Hsu SH, et al. Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sportsmed 2011;39:42-51.
5. Interventional procedure overview of autologous blood injection for tendinopathy. NICE interventional procedures guidance 2008.
6. Nauth A, Miclau T, Bhandari M, et al. Use of osteobiologics in the management of osteoporotic fractures. J Orthop Trauma 2011;25 (Suppl 2):S51-5.
7. Lu-Yao GL, Keller RB, Littenberg B, et al. Outcomes after displaced fractures of the femoral neck. A meta-analysis of one hundred and six published reports. J Bone Joint Surg Am 1994;76:15-25. (Pubitemid 24081800)
8. Parker MJ, Raghavan R, Gurusamy K. Incidence of fracture-healing complications after femoral neck fractures. Clin Orthop Relat Res 2007;458:175-9. (Pubitemid 46701374)
9. Parker MJ, Khan RJK, Crawford J, et al. Hemiarthroplasty versus internal fixation for displaced intracapsular hip fractures in the elderly. A randomised trial of 455 patients. J Bone Joint Surg Br 2002;84:1150-5. (Pubitemid 35414415)
10. Griffin X, Parsons N, Achten J, et al. Warwick Hip Trauma Study: a randomised clinical trial comparing interventions to improve outcomes in internally fixed intracapsular fractures of the proximal femur. Protocol for the WHiT Study. BMC Musculoskelet Disord 2010;11:184.
11. National Hip Fracture Database. http://www.nhfd.co.uk/003/hipfractureR. nsf/resourceDisplay?openform (accessed Oct 2012).
12. Parker MJ. Garden grading of intracapsular fractures: meaningful or misleading? Injury 1993;24:241-2. (Pubitemid 23147670)
13. Mishra A, Harmon K, Woodall J, et al. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 2012;13:1185-95.
14. Kevy SV, Jacobson MS, Mandle RJ. Analysis of GenesisCS Component Concentrating System: preparation of concentrated platelet product. Cambridge, MA: BioSciences Research Associates Inc, 2006:1-2.
15. Everts PAM, Mahoney B, C Hoffman JJML, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006;24:165-71. (Pubitemid 44669347)
16. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108. (Pubitemid 127453463)
17. Griffin XL, Wallace D, Parsons N, et al. Platelet rich therapies for long bone healing in adults. Cochrane Database Syst Rev 2012;7: CD009496.
18. Griffin XL, Smith CM, Costa ML. The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury 2009;40:158-62.
19. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clin Trials 1990;11:116-28. (Pubitemid 20136185)
20. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
21. Team RDC. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2012.
22. Cmprsk package. cran.r-project.org/web/packages/cmprsk/(accessed Sep 2012).
23. The Management of Hip Fracture in Adults. 1st edn. National Clinical Guideline Centre 2011. http://www.ncgc.ac.uklast (accessed Oct 2012).